关注
Jasleen K. Sodhi
Jasleen K. Sodhi
在 ucsf.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Association of CYP2C9*2 With Bosentan‐Induced Liver Injury
SM Markova, T De Marco, N Bendjilali, EA Kobashigawa, J Mefford, ...
Clinical Pharmacology & Therapeutics 94 (6), 678-686, 2013
752013
A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834
JK Sodhi, S Wong, DS Kirkpatrick, L Liu, SC Khojasteh, CECA Hop, ...
Drug Metabolism and Disposition 43 (6), 908-915, 2015
592015
Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties
J Gunzner-Toste, G Zhao, P Bauer, T Baumeister, AJ Buckmelter, ...
Bioorganic & medicinal chemistry letters 23 (12), 3531-3538, 2013
432013
Successful and unsuccessful prediction of human hepatic clearance for lead optimization
JK Sodhi, LZ Benet
Journal of medicinal chemistry 64 (7), 3546-3559, 2021
402021
Understanding drug–drug interaction and pharmacogenomic changes in pharmacokinetics for metabolized drugs
LZ Benet, CM Bowman, ML Koleske, CL Rinaldi, JK Sodhi
Journal of pharmacokinetics and pharmacodynamics 46, 155-163, 2019
402019
Minimizing CYP2C9 inhibition of exposed-pyridine NAMPT (nicotinamide phosphoribosyltransferase) inhibitors
M Zak, P Yuen, X Liu, S Patel, D Sampath, J Oeh, BM Liederer, W Wang, ...
Journal of Medicinal Chemistry 59 (18), 8345-8368, 2016
372016
Investigating the Theoretical Basis for In VitroIn Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental Pathways
LZ Benet, JK Sodhi
The AAPS journal 22 (5), 120, 2020
352020
Pharmacogenomics in the era of next generation sequencing–from byte to bedside
LE Russell, Y Zhou, AA Almousa, JK Sodhi, CK Nwabufo, VM Lauschke
Drug Metabolism Reviews 53 (2), 253-278, 2021
312021
Are there any experimental perfusion data that preferentially support the dispersion and parallel-tube models over the well-stirred model of organ elimination?
JK Sodhi, HJ Wang, LZ Benet
Drug Metabolism and Disposition 48 (7), 537-543, 2020
302020
Can In Vitro–In Vivo Extrapolation Be Successful? Recognizing the Incorrect Clearance Assumptions
LZ Benet, JK Sodhi
Clinical Pharmacology & Therapeutics 111 (5), 1022-1035, 2022
252022
There is only one valid definition of clearance: critical examination of clearance concepts reveals the potential for errors in clinical drug dosing decisions
LZ Benet, JK Sodhi, G Makrygiorgos, A Mesbah
The AAPS journal 23 (3), 67, 2021
252021
Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data
J Yadav, M El Hassani, J Sodhi, VM Lauschke, JH Hartman, LE Russell
Drug metabolism reviews 53 (2), 207-233, 2021
242021
How transporters have changed basic pharmacokinetic understanding
LZ Benet, CM Bowman, JK Sodhi
The AAPS journal 21 (6), 103, 2019
232019
The extended clearance concept following oral and intravenous dosing: theory and critical analyses
LZ Benet, CM Bowman, S Liu, JK Sodhi
Pharmaceutical research 35, 1-12, 2018
212018
Computational predictions of the site of metabolism of cytochrome P450 2D6 substrates: comparative analysis, molecular docking, bioactivation and toxicological implications
KA Ford, G Ryslik, J Sodhi, J Halladay, D Diaz, D Dambach, M Masuda
Drug Metabolism Reviews 47 (3), 291-319, 2015
202015
Intestinal efflux transporters P-gp and BCRP are not clinically relevant in apixaban disposition
JK Sodhi, S Liu, LZ Benet
Pharmaceutical research 37, 1-13, 2020
182020
Volume of distribution is unaffected by metabolic drug–drug interactions
JK Sodhi, CH Huang, LZ Benet
Clinical pharmacokinetics 60 (2), 205-222, 2021
122021
1-Aminobenzotriazole coincubated with (S)-warfarin results in potent inactivation of CYP2C9
JK Sodhi, KA Ford, S Mukadam, S Wong, CECA Hop, SC Khojasteh, ...
Drug Metabolism and Disposition 42 (5), 813-817, 2014
122014
The necessity of using changes in absorption time to implicate intestinal transporter involvement in oral drug-drug interactions
JK Sodhi, LZ Benet
The AAPS journal 22 (5), 111, 2020
112020
The effects of drug metabolizing enzyme inhibitors on hepatic efflux and uptake transporters
J Cheong, JS Halladay, E Plise, JK Sodhi, L Salphati
Drug metabolism letters 11 (2), 111-118, 2017
112017
系统目前无法执行此操作,请稍后再试。
文章 1–20